Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	29318
Country	United States

Received	2016-08-08 08:46
Peer-Review Started	2016-08-10 14:16
To Make the First Decision	2016-09-06 11:10
Return for Revision	2016-09-12 16:21
Revised	2016-09-25 17:02
Second Decision	2016-11-10 14:23
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-11-22 15:37
Articles in Press	2016-11-22 15:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-12-28 20:30
Publish the Manuscript Online	2017-01-12 12:07

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Tripti Khare, Sharad Khare and Jamal A Ibdah
Funding Agency and Grant Number
Corresponding Author	Jamal A Ibdah, MD, PhD, Professor, Director, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri-Columbia, 1 University Blvd, Columbia, MO 65212, United States. ibdahj@health.missouri.edu
Key Words	Proteomics; Cancer; Biomarker; Hepato­cellular carcinoma
Core Tip	Despite ongoing development in treatment for hepatocellular carcinoma (HCC), effective biomarkers for diagnosis and treatment for HCC are not available. Profiling of proteins puts proteomics on the forefront to understand promising new biomarkers and drug targets for HCC. HCC proteome database would be an important step towards identifying tumor associated proteins as potential therapeutic targets in the treatment of HCC.
Publish Date	2017-01-12 12:07
Citation	Khare T, Khare S, Ibdah JA. Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma. World J Gastrointest Oncol 2017; 9(1): 1-3
URL	http://www.wjgnet.com/1948-5204/full/v9/i1/1.htm
DOI	http://dx.doi.org/10.4251/wjgo.v9.i1.1

Full Article (PDF)	WJGO-9-1.pdf
Full Article (Word)	WJGO-9-1.doc
Manuscript File	29318-Review.docx
Answering Reviewers	29318-Answering reviewers.pdf
Audio Core Tip	29318-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	29318-Conflict-of-interest statement.pdf
Copyright License Agreement	29318-Copyright assignment.pdf
Peer-review Report	29318-Peer-review(s).pdf
Scientific Misconduct Check	29318-Scientific misconduct check.pdf
Scientific Editor Work List	29318-Scientific editor work list.pdf